T&R Biofab Co., Ltd Logo

T&R Biofab Co., Ltd

Develops 3D bioprinted scaffolds for tissue repair in orthopedics, surgery, and dentistry.

246710 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 시흥시 마유로 96, 시흥시
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in regenerative medicine and tissue engineering. Leveraging its proprietary 3D bioprinting technology, the company develops and commercializes products designed for tissue and organ regeneration and reconstruction. Its core offerings include 3D-printed bioresorbable scaffolds, bio-inks, bio-surgical solutions, organoids, and induced pluripotent stem cells (hiPSC). These advanced solutions cater to various medical fields, including orthopedics, plastic surgery, and dentistry, aiming to provide innovative treatments for tissue repair and transplantation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-09-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-16 00:00
Registration Form
[기재정정]증권신고서(지분증권) (2025.10)
Korean 3.9 MB
2025-09-16 00:00
Prospectus
[기재정정]투자설명서
Korean 3.8 MB
2025-09-15 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-09-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 97.7 KB
2025-09-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 96.0 KB
2025-09-08 00:00
Share Issue/Capital Change
유상증자1차발행가액결정
Korean 8.0 KB
2025-09-08 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유무상증자결정)
Korean 54.6 KB
2025-09-08 00:00
Share Issue/Capital Change
[발행조건확정]증권신고서(지분증권)
Korean 568.9 KB
2025-09-08 00:00
Prospectus
투자설명서
Korean 3.7 MB
2025-09-08 00:00
Share Issue/Capital Change
권리락 (유상증자)
Korean 3.5 KB
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 123.1 KB
2025-08-22 00:00
Registration Form
[기재정정]증권신고서(지분증권) (2025.10)
Korean 4.9 MB
2025-08-21 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.9 MB

Automate Your Workflow. Get a real-time feed of all T&R Biofab Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for T&R Biofab Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive, pre-approval technologies for the spinal stabilization market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
UXN Co., Ltd. Logo
Develops advanced continuous glucose monitoring systems and sensors for diabetes management.
South Korea 337840
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
A global provider of medical devices and genetic testing services for IVF clinics to improve outcomes.
Sweden VITR
Vitruvia Medical AG Logo
Circular economy provider for robotic surgery instruments for European clinics and hospitals.
Germany 991
Wonbiogen Co.,Ltd. Logo
Develops and manufactures advanced wound care solutions and medical materials.
South Korea 307280
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO

Talk to a Data Expert

Have a question? We'll get back to you promptly.